. Author manuscript; available in PMC: 2013 Dec 24.

Published in final edited form as: Schizophr Res. 2011 Jun 29;131(0):10.1016/j.schres.2011.05.028. doi: 10.1016/j.schres.2011.05.028

Table 1.

Clinical and Demographic Characteristics

	Schizophrenia (n = 35)	Healthy Controls (n = 32)	t or χ²	p
	Mean (SD)	Mean (SD)
Age (years)	37.03 (8.12)	34.91 (8.95)	−1.02	.31
Sex (% male)	54.3%	56.3%	.03	.87
Race (% Caucasian)	28.6%	53.1%	9.58	.21
Education	13.06 (2.40)	15.16 (2.40)	3.56	.001
Parental education (years)	14.00 (3.80)	14.40 (2.62)	.48	.63
Medication (% Taking)
Antipsychotics (%)	94.29%	N/A
Typical antipsychotics	8.57%	N/A
Atypical antipsychotics	80%	N/A
Both typical and atypicals	5.71%	N/A
SANS Global Anhedonia/Asociality	1.29 (1.36)
Positive Symptoms	2.69 (3.37)	N/A
Negative Symptoms	5.49 (3.14)	N/A
Disorganization Symptoms	2.03(1.84)

Note. Positive symptoms consisted of the mean of the global scores for hallucinations and delusions; Negative symptoms consisted of the mean of the global scores for anhedonia/asociality, avolition/apathy, alogia, and affective flattening; Disorganization symptoms consisted of the mean of the global scores for inappropriate affect, positive formal thought disorder, and bizarre behavior.

Abbreviations: CON, healthy controls; SCZ, individuals with schizophrenia; SANS, scale for the assessment of negative symptoms